Article in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Kaitlin K ScholandDepartment of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-7556-8950
Laura SchaeferDepartment of Molecular Virology and Microbiology, Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0003-1628-2893
Gowthaman GovindarajanDepartment of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-9347-1239
Zhiyuan YuDepartment of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0003-0785-9822
Jeremias G GallettiDepartment of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-5118-2540
Cintia S de PaivaDepartment of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA. cintiadp@bcm.edu.ORCID 0000-0002-9057-5494
Funding
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
VISION RESEARCH CENTERP30EY002520 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$14.8M
P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan · 2011 to 2026
$10.5M
VISUAL SCIENCEST32EY007001 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$3.7M
Investigating the anti-inflammatory mechanisms of calorie restriction in the aged lacrimal glandR01EY035333 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI CINTIA S. DE PAIVA, Helen P. Makarenkova · 2024 to 2026
$2.1M
Defining the interplay of interferon-gamma and cathepsin S in age-related dry eyeR01EY030447 · NEI · BAYLOR COLLEGE OF MEDICINE · PI DE PAIVA, CINTIA S. · 2020 to 2023
$1.6M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
THRESHOLD AND NOISE DETERMINATIONS IN RODS AND CONESF32EY007001 · NEI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HORNSTEIN, ERIC P · 1999 to 2001
$73k
Agencia Nacional de Promoción Científica y Tecnológica PICT 2020-00138Agencia Nacional de Promoción Científica y Tecnológica PICT 2021-00109CPRIT CPRIT-RP180672National Institutes of Health (US) CA125123National Institutes of Health (US) RR024574NCI NIH HHS P30 CA125123NCI NIH HHS P30CA125123NCRR NIH HHS S10 RR024574NEI NIH HHS EY-002520NEI NIH HHS EY007001NEI NIH HHS EY021725NEI NIH HHS F32 EY007001NEI NIH HHS P30 EY002520NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY030447NEI NIH HHS R01EY030447NEI NIH HHS R01 EY035333NEI NIH HHS R01EY035333NEI NIH HHS T32 EY007001Wellcome TrustWellcome Trust 221859/Z/20/Z
6 · The paper itself
Abstract
CD25KO mice are a model of Sjögren disease. CD25KO mice have severe inflammation and infiltrating lymphocytes to the lacrimal glands (LG). Whether the pathogenicity of CD25KO CD4
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Aged regulatory T cells fail to control autoimmune lacrimal gland pathogenic CD4 · full record | OpenQuestion